AUTOLUS THERAPEUTICS PLC AUTL
SPON ADS · ADR · CUSIP 05280R100 · ISIN US05280R1005
Company in London, United Kingdom
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersUnited Kingdom
- Founded2014
- Websiteautolus.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($1.0k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $13.20.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| MAK Capital Fund LP 13G · exempt (held before listing) +1.3 pts · filed 2026-05-15 | 12.6% |
| Syncona Portfolio Ltd 13G · exempt (held before listing) filed 2025-05-07 | 10.8% |
| ARMISTICE CAPITAL, LLC 13G · institution -0.3 pts · filed 2026-08-14 | 5.6% |
PPF Group a.s.
13D · may seek influence
filed 2026-08-28
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented to include the following: The transactions described in this Amendment No. 11 were undertaken solely to effect an internal reorganization of the PPF group of companies. Such transactions did not involve any change in the ultimate beneficial ownership of, or the ultimate voting or dispositive power over, the Ordinary Shares reported herein, and were not undertaken with any purpose of, or with the effect of, changing or influencing control of the Issuer. Other than as described herein, the Reporting Persons do not have any current plans or proposals which relate to or would result in any of the actions described in subparagraphs (a) through (j) above. Full filing |
5.6% |
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| Capital World Investors 0.01% of their portfolio | 2.2m $29.0m | — |
| SCHRODER INVESTMENT MANAGEMENT GROUP 0.05% of their portfolio | 2.1m $27.7m | — |
| Tetragon Partners GP Ltd 2.55% of their portfolio | 1.3m $17.2m | — |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 941.5k $12.4m | — |
| JUPITER ASSET MANAGEMENT LTD 0.29% of their portfolio | 705.4k $9.3m | — |
| Alphabet Inc. 0.56% of their portfolio | 699.4k $9.2m | — |
| MARSHALL WACE, LLP 0.07% of their portfolio | 680.2k $9.0m | — |
| MILLENNIUM MANAGEMENT LLC 0.02% of their portfolio | 676.5k $8.9m | — |
| Capital International Investors 0.00% of their portfolio | 674.9k $8.9m | — |
| Artal Group S.A. 0.28% of their portfolio | 500.0k $6.6m | — |
| Cormorant Asset Management, LP 0.28% of their portfolio | 480.0k $6.3m | — |
| Point72 Asset Management, L.P. 0.02% of their portfolio | 315.8k $4.2m | — |
| Granahan Investment Management, LLC 0.19% of their portfolio | 305.2k $4.0m | — |
| VICTORY CAPITAL MANAGEMENT INC 0.00% of their portfolio | 247.2k $3.3m | — |
| BlackRock Inc. 0.00% of their portfolio | 242.5k $3.2m | — |
| FMR LLC 0.00% of their portfolio | 212.1k $2.8m | — |
| Alyeska Investment Group, L.P. 0.04% of their portfolio | 207.3k $2.7m | — |
| BAKER BROS. ADVISORS LP 0.01% of their portfolio | 156.8k $2.1m | — |
| Vident Investment Advisory, LLC 0.10% of their portfolio | 118.9k $1.6m | — |
| DAFNA Capital Management LLC 0.45% of their portfolio | 100.0k $1.3m | — |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 78.2k $1.0m | — |
| Bellevue Group AG 0.01% of their portfolio | 62.2k $821.0k | — |
| Weiss Multi-Strategy Advisers LLC 0.01% of their portfolio | 50.0k $660.0k | — |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 40.7k $537.0k | — |
| MPM BIOIMPACT LLC 0.19% of their portfolio | 39.7k $525.0k | — |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 38.3k $504.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 38.2k $504.0k | — |
| VIRTUS ADVISERS, LLC 0.07% of their portfolio | 32.6k $430.0k | — |
| SG Americas Securities, LLC 0.00% of their portfolio | 26.4k $349.0k | — |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 23.9k $316.0k | — |
| LADENBURG THALMANN FINANCIAL SERVICES INC. 0.00% of their portfolio | 22.5k $297.0k | — |
| A.R.T. Advisors, LLC 0.01% of their portfolio | 17.8k $235.0k | — |
| TD Asset Management Inc 0.00% of their portfolio | 17.1k $225.0k | — |
| OXFORD ASSET MANAGEMENT LLP 0.01% of their portfolio | 14.4k $190.0k | — |
| BURRAGE CAPITAL MANAGEMENT LLC 0.12% of their portfolio | 13.1k $173.0k | — |
| STATE STREET CORP 0.00% of their portfolio | 12.7k $168.0k | — |
| BANK OF MONTREAL /CAN/ 0.00% of their portfolio | 12.0k $158.0k | — |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 11.5k $152.0k | — |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 10.7k $141.0k | — |
| Aperio Group, LLC 0.00% of their portfolio | 10.2k $134.0k | — |
| Legal & General Group Plc 0.00% of their portfolio | 3.5k $46.0k | — |
| UBS Group AG 0.00% of their portfolio | 3.2k $43.0k | — |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.2k $29.0k | — |
| CITIGROUP INC 0.00% of their portfolio | 2.0k $27.0k | — |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1.8k $24.0k | — |
| Marshall Wace North America L.P. 0.00% of their portfolio | 980 $13.0k | — |
| Advisor Group, Inc. 0.00% of their portfolio | 700 $9.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 672 $9.0k | — |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 460 $6.0k | — |
| US BANCORP \DE\ 0.00% of their portfolio | 242 $3.0k | — |
| EXANE DERIVATIVES 0.00% of their portfolio | 180 $2.3k | — |
| Daiwa Securities Group Inc. 0.00% of their portfolio | 168 $2.0k | — |
| Parallel Advisors, LLC 0.00% of their portfolio | 116 $2.0k | — |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 85 $1.0k | — |
| BARCLAYS PLC 0.00% of their portfolio | 18 $0 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |
| IFP Advisors, Inc 0.00% of their portfolio | 0 $0 | — |